Author:
Launonen V, ,Laake K,Huusko P,Niederacher D,Beckmann M W,Barkardottir R B,Geirsdottir E K,Gudmundsson J,Rio P,Bignon Y-J,Seitz S,Scherneck S,Bièche I,Champème M-H,Birnbaum D,White G,Varley J,Sztán M,Olah E,Osorio A,Benitez J,Spurr N,Velikonja N,Peterlin B,Borg Å,Cleton-Jansen A-M,Devilee P,Bloigu R,Lidereau R,Børresen-Dale A-L,Winqvist R
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Arai, Y., Hosoda, F., Nakayama, K. & Ohki, M. (1996). A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2–q23.3. Genomics 35: 196–206.
2. Bhattacharya, S., Wilson, T. M. E., Wojciechowski, A. P., Volpe, C. P. & Scott, J. (1991). Hypervariable polymorphism in the APOC3 gene. Nucleic Acids Res 17: 4799
3. Bièche, I. & Lidereau, R. (1995). Genetic alterations in breast cancer. Genes Chromosomes Cancer 14: 227–251.
4. Furnari, B., Rhind, N. & Russell, P. (1997). Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science 277: 1495–1497.
5. Gabra, H., Watson, J. E. V., Taylor, K. J., Mackay, J., Leonard, R. C. F., Steel, C. M., Porteous, D. J. & Smyth, J. F. (1996). Definition and refinement of a region of loss of heterozygosity at 11q23.3–q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56: 950–954.